LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix SA, a technology innovation company focused on addressing gene and cell therapy manufacturing gaps, announced today the launch of NBX-HEK293, the ...
Paper reports two-fold higher full-to-empty rAAV ratio using NBX1P01 compared to a leading commercial HEK293 cell line Lausanne, Switzerland – 18 February 2026 – NewBiologix S.A., a biotechnology ...
Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab ® HEK293 HCP Type SN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results